This website uses cookies to enhance the user experience.
||
S

SMERUD MEDICAL RESEARCH INTERNATIONAL AS970 913 297

Other healthcare services
Limited company
Thunes vei 2 0274 OSLO, Norge

SMERUD MEDICAL RESEARCH INTERNATIONAL AS

Home | SMERUD MEDICAL RESEARCH INTERNATIONAL AS
SMERUD, a leading CRO, offers full-service clinical solutions to biotech, pharma, med-tech & academic sponsors.

Keywords

environmental health protectioninformation servicecompanies' health servicethe hse servicemental health work

Links

Organization

Chairman of the board
Years since formation
30 years
since Feb 20, 1995
Type
Limited company
VAT registered
Yes
Number of employees
12

Ownership

Number of shares and share classes
1,100
1 share class
Total number of shareholders
1
company
Belongs to group of

Financials

Total operating income 2024
108,307,634
NOK
Annual total result 2024
8,964,355
NOK
Total equity 2024
26,451,084
NOK
Last update: Jul 12, 2025

Management

Management / administration

NameRoleShares
Managing Director/CEO
100 %
indirectly

Board

NameRoleShares
Chairman
100 %
indirectly
Alternate Member-

Others

NameRoleShares
B
BANG-OLSEN REVISJON AS
Auditor-
M
MGI REGNSKAP AS
Accountant-

Top 10 individual shareholders

NameRoleShares
Managing Director/CEO, Chairman
100 %
indirectly
Last update: Sep 17, 2024

Ownership

Company shareholders

NameShare classTotal number of sharesShare
S
SMERUD HOLDING AS
Ordinary shares
1,100
100 %

Shares owned by the SMERUD MEDICAL RESEARCH INTERNATIONAL AS

NameShare classTotal number of sharesShare
B
BIONOR HOLDING AS
NO0010813736
1,275,760
2.8 %
I
INSULIFE AS
NO0012753625
1,219,512
1.71 %
I
INANOD AS
Ordinary shares
60,000
1.58 %
I
IMMUNOR AS
Ordinary shares
2,551,520
0.46 %
S
SERODUS AS
NO0010549801
26,467
0.14 %
P
PHOTOCURE ASA
NO0010000045
350
< 0.01 %
P
PCI BIOTECH HOLDING ASA
NO0010405640
35
< 0.01 %
Last update: Jun 2, 2025

Group structure

  • Total operating income 2024: NOK 0
    Operating profit 2024: NOK -95,650
    Employees: 0

Financials

in NOK

Summary

Year2024202320222021
Total operating income
108,307,634
95,339,773
63,455,965
37,973,563
Annual Total Result
8,964,355
15,338,136
5,811,649
2,191,854
Total assets
47,612,363
40,165,876
47,466,976
28,828,211
Total liabilities
21,161,279
22,305,559
34,648,742
21,821,626
Total equity
26,451,084
17,860,316
12,818,234
7,006,584

P&L

Year2024202320222021
Total operating income
108,307,634
95,339,773
63,455,965
37,973,563
Total operating costs
97,539,202
74,668,276
56,430,438
35,301,539
Operating result
10,768,433
20,671,497
7,025,527
2,672,024
Financial income/costs
-376,619
-512,370
-1,213,877
-480,169
Profit before tax
10,391,814
20,159,128
5,811,649
2,191,854
Total tax & extraordinary income/cost
1,427,459
4,820,992
0
0
Annual Total Result
8,964,355
15,338,136
5,811,649
2,191,854

Balance overview

Year2024202320222021
Total fixed assets
4,133,750
4,290,897
4,431,288
450,817
Total current assets
43,478,613
35,874,979
43,035,688
28,377,394
Total assets
47,612,363
40,165,876
47,466,976
28,828,211
Short term debt
21,161,279
22,305,559
34,648,742
21,821,626
Long term debt
0
0
0
0
Total liabilities
21,161,279
22,305,559
34,648,742
21,821,626
Contributed capital
5,672,547
5,672,547
5,672,547
5,672,547
Retained earnings
20,778,537
12,187,769
7,145,687
1,334,037
Total equity
26,451,084
17,860,316
12,818,234
7,006,584
Total equity and liabilities
47,612,363
40,165,876
47,466,976
28,828,211

Classification

Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
Q
Main industrial area
Human health and social work activities
86
Activity
Human health activities
86.9
Main industrial group
Other human health activities
86.90
Industrial group
Other human health activities
86.904
Industrial group
Other preventive health care